RxDoctor Payments Data

Pedro Serrantgotos

Internal Medicine · Slidell, LANPI 1740287820

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.

$2,876in general payments, 2019–2025

Across 202 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$393
  • AstraZeneca$344
  • Pfizer$282
  • Merck$267
  • Novo Nordisk$229
  • Amgen$189
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,866100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,876 in reported general payments places this provider in the 80th percentile of 1,528 internal medicine providers in Louisiana.

See all internal medicine providers in Louisiana →

Other internal medicine in Slidell

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →